|
| | cycrimine Basic information |
| Product Name: | cycrimine | | Synonyms: | 1-cyclopentyl-1-phenyl-3-piperidin-1-ylpropan-1-ol;1-cyclopentyl-1-phenyl-3-piperidino-propan-1-ol;1-Piperidinepropanol, a-cyclopentyl-a-phenyl-;cycrimine;1-Phenyl-1-cyclopentyl-3-piperidino-1-propanol;α-Cyclopentyl-α-phenyl-1-piperidine-1-propanol;1-cyclopentyl-1-phenyl-3-piperidin-1-yl-propan-1-ol;cycrimine USP/EP/BP | | CAS: | 77-39-4 | | MF: | C19H29NO | | MW: | 287.444 | | EINECS: | 201-024-6 | | Product Categories: | | | Mol File: | 77-39-4.mol |  |
| | cycrimine Chemical Properties |
| Melting point | 90-92°C | | Boiling point | 125-135 °C(Press: 0.02 Torr) | | density | 1.057±0.06 g/cm3(Predicted) | | storage temp. | -20°C Freezer, Under inert atmosphere | | solubility | Chloroform (Slightly), Ethyl Acetate, Methanol (Slightly) | | form | Solid | | pka | 14.40±0.29(Predicted) | | color | Off-White to Pale Yellow | | Stability: | Stable under recommended storage conditions., Stable Under Recommended Storage C |
| | cycrimine Usage And Synthesis |
| Originator | Pagitane,Lilly,US,1953 | | Uses | Cycrimine is a cholinolytic anti-Parkinson drug which can cause neuromuscular blockades in isolated rat diaphragms. | | Definition | ChEBI: A member of the class of piperidines that is 3-(piperidin-1-yl)propan-1-ol in which one of the hydrogen atoms at the 1-position is substituted by cyclopentyl, and the other is substituted by phenyl. A central anticholinergic, it is used as its hydrochlorid
salt in the management and treatment of Parkinson's disease. | | Manufacturing Process | The manufacture of the cyclohexyl analog is as follows. Phenyl magnesium
bromide was prepared from 48.5 g (0.308 mol) of bromobenzene, 7 g (0.29
mol) of magnesium, and 125 ml of dry ether. To it was added at 5°C over a
period of ? hour 40 g (0.18 mol) of cyclohexyl β-(N-piperidyl)-ethyl ketone
(BP 115° to 117°C/1 mm) in 125 ml of dry ether. The mixture was allowed
slowly to come to room temperature, refluxed for one hour, and then poured
into ice containing 80 ml of concentrated hydrochloric acid. Ammonium chloride (100 g) and 200 ml of concentrated ammonium hydroxide were
added and the organic layer was separated. After drying and removing the
solvent, the residue was distilled under reduced pressure. The base distilled at
158° to 170°C (1 mm) and solidified. Upon recrystallization from methanol it
melted at 112° to 113°C. | | Brand name | Pagitane
(Lilly). | | Therapeutic Function | Muscle relaxant, Antiparkinsonian |
| | cycrimine Preparation Products And Raw materials |
|
